Patents by Inventor Gita Shah

Gita Shah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRROLIDINE DERIVATIVES AS FACTOR XA INHIBITORS
    Publication number: 20070155745
    Abstract: The invention relates to compounds of formula (I) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Application
    Filed: October 11, 2006
    Publication date: July 5, 2007
    Inventors: Chuen Chan, Julie Hamblin, Henry Kelly, Nigel King, Andrew Mason, Vipulkumar Patel, Stefan Senger, Gita Shah, Nigel Watson, Helen Weston, Caroline Whitworth, Robert Young
  • PYRROLIDINE DERIVATIVES AS FACTOR XA INHIBITORS
    Publication number: 20070142375
    Abstract: The invention relates to compounds of formula (I) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Application
    Filed: October 11, 2006
    Publication date: June 21, 2007
    Inventors: Chuen CHAN, Julie Hamblin, Henry Kelly, Nigel King, Andrew Mason, Vipulkumar Patel, Stefan Senger, Gita Shah, Nigel Watson, Helen Weston, Caroline Whitworth, Robert Young
  • PYRROLIDINE DERIVATIVES AS FACTOR XA INHIBITORS
    Publication number: 20070142374
    Abstract: The invention relates to compounds of formula (I) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Application
    Filed: October 11, 2006
    Publication date: June 21, 2007
    Inventors: Chuen CHAN, Julie Hamblin, Henry Kelly, Nigel King, Andrew Mason, Vipulkumar Patel, Stefan Senger, Gita Shah, Nigel Watson, Helen Weston, Carolin Whitworth, Robert Young
  • Pyrrolydin-2-one derivatives as inhibitors of thrombin and factor xa
    Publication number: 20060166985
    Abstract: The invention relates to novel chemical compounds, pharmaceutically acceptable derivatives thereof, processes for their preparation, pharmaceutical compositions containing them, and to their use in medicine, particularly use in the amelioration of a clinical condition for which a thrombin inhibitor is indicated.
    Type: Application
    Filed: December 4, 2003
    Publication date: July 27, 2006
    Inventors: Alan Borthwick, Chuen Chan, Henry Kelly, Simon Peace, Stefan Senger, Gita Shah, Stefan Smith, Steven Smith, Nigel Watson, Robert West, Robert Young
  • Chemical compounds
    Publication number: 20060160886
    Abstract: The invention relates to compounds of formula (Ic) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Application
    Filed: March 17, 2006
    Publication date: July 20, 2006
    Inventors: Chuen Chan, Julie Hamblin, Henry Kelly, Nigel King, Andrew Mason, Vipulkumar Patel, Stefan Senger, Gita Shah, Nigel Watson, Helen Weston, Caroline Whitworth, Robert Young
  • Chemical compounds
    Publication number: 20060160885
    Abstract: The invention relates to compounds of formula (Ic) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Application
    Filed: March 17, 2006
    Publication date: July 20, 2006
    Inventors: Chuen Chan, Julie Hamblin, Henry Kelly, Nigel King, Andrew Mason, Vipulkumar Patel, Stefan Senger, Gita Shah, Nigel Watson, Helen Weston, Caroline Whitworth, Robert Young
  • Crystalline form
    Publication number: 20060124049
    Abstract: The present invention includes (E)-2-(5-Chlorothien-2-yl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl)ethenesulfonamide in substantially crystalline form, pharmaceutical formulations thereof, processes for preparing it, and its use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Application
    Filed: December 4, 2003
    Publication date: June 15, 2006
    Inventors: Philip Dell Orco, Henry Kelly, Gita Shah, Nigel Watson, Robert Young
  • Pyrrolidine derivatives as factor xa inhibitors
    Publication number: 20050107379
    Abstract: The invention relates to compounds of formula (I) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Application
    Filed: June 6, 2002
    Publication date: May 19, 2005
    Inventors: Chuen Chan, Julie Hamblin, Henry Kelly, Nigel King, Andrew Mason, Vipulkumar Patel, Stefan Senger, Gita Shah, Nigel Watson, Helen Weston, Caroline Whitworth, Robert Young
  • Pyrrolidine-2-ones as factor xa inhibitors
    Publication number: 20050059726
    Abstract: The present invention relates to novel compounds and pharmaceutically acceptable derivatives thereof. The invention also relates to processes for the preparation of the compounds, pharmaceutical compositions containing the compounds, and to the use of compounds in medicine, particularly in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
    Type: Application
    Filed: December 20, 2002
    Publication date: March 17, 2005
    Inventors: Alan Borthwick, Chuen Chan, Henry Kelly, Nigel King, Savvas Kleanthous, Andrew Mason, Ivan Pinto, Derek Pollard, Stefan Senger, Gita Shah, Nigel Watson, Robert Young